Tauranga-based company’s natural pharmaceutical products to hit shelves in all 50 US states
Kiwi natural pharmaceutical company, TRG Natural Pharmaceuticals (formerly HoneyLab), will see its products sold across
all 50 states in the US as part of its licencing deal with Taro Pharmaceuticals. This deal is a key contributor to TRG’s
10-20 fold increase in sales this year.
Launched under the brand Bee RX, the range includes topical kānuka honey based cold sore, acne, and rosacea treatments.
First launched online at Target, the first drop of product sold out within hours. Bee RX will also be sold in major
pharmacy chains, in total representing more than 21,000 stores and giving TRG a strong foothold across every state in
The brand is being fronted by Golden Globe and Emmy nominated actress and singer, Mandy Moore
, well-known for the TV show ‘This is Us,’
and Erika Thompson
of Texas Bee Works is the Bee RX ambassador.
TRG Natural Pharmaceuticals CEO, Anthony Lawler, says seeing stock on international shelves is a huge achievement for
“Seeing our products on shelves in the US has been a key milestone for TRG. To see Bee RX selling out within hours of
going on sale has surpassed our expectations.”
Mr Lawler says the business has navigated the unique challenges of a global pandemic on supply chain management, and
“We have faced our fair share of Covid-19 induced setbacks. Not only have supply chain issues impacted our manufacturing
capacity and product distribution timelines, but closing deals and building important relationships with distributors
such as Taro can be difficult when you can’t meet face-to-face.”Diving back into global business
With international travel off the cards for the last 18 months, founder Dr Shaun Holt is travelling to the US in August
for two months to support TRG’s rapid expansion into the market. He will also visit Europe until year end to open the
door into these territories.
A medical doctor and natural health expert, Dr Holt recently featured on Netflix’s documentary (Un)Well
, bringing much international attention as well as praise for his innovation in the health and wellbeing retail space.
He was also a finalist in the 2019 EY New Zealand Entrepreneur of the Year awards.
“While we have built strong relationships with licensing partners virtually, video calls can only get you so far. It’s
vital for us to continue building relationships and meeting potential new licensing partners face-to-face,” Dr Holt
“TRG Natural Pharmaceuticals has ambitious plans to continue expanding globally, and I look forward to showcasing our
scientifically-proven New Zealand natural healthcare products in person.”The evolution to TRG Natural Pharmaceuticals
HoneyLab has changed its name to TRG Natural Pharmaceuticals, having greatly evolved in the past decade. Starting out as
HoneyLab and specialising in pharmaceutical-grade, clinically proven honey-based healthcare products, the company is
currently best known for its cold sore product, Honevo.
While honey is still important for TRG, the company is now developing other natural ingredients to create clinically
proven natural healthcare products.
“The name TRG Natural Pharmaceuticals comes from the airport city code for Tauranga where the company was founded. We
needed a name that better aligns to our future plans.”
“The name change represents a need to convey how the company has expanded and to better reflect the pipeline of products
currently in development. We look forward to sharing these in due course, Dr Holt concludes.About TRG Natural Pharmaceuticals
TRG Natural Pharmaceuticals (formerly HoneyLab) is a New Zealand pharmaceutical company developing health products from natural
sources. The company has undertaken the world’s largest programme of medical honey research. Their patented topical
honey formulation, Honevo, is proven in the treatment of cold sores, rosacea and acne, with clinical results published
in the acclaimed British Medical Journal Open.
The licence agreement with Taro Pharmaceuticals, TRG Natural Pharmaceuticals’ first large-scale deal, covers the
territories of USA, Canada and Israel and covers eight products: the topical kānuka honey range Honevo, the bee
venom-based cosmetic range Kanu, and Rubeeven, a natural topical treatment for joint and muscle pain.